SMS Pharmaceuticals Ltd receives Certificate of Suitability approval for Ibuprofen by EDQM

SMS Pharmaceuticals Limited has received CEP approval for Ibuprofen from the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Commenting on this Mr. P. Vamsi Krishna, Executive Director - SMS Pharmaceuticals Limited said, "We are pleased to receive the CEP approval for Ibuprofen by the EDQM. This we believe is a testimony of the company's quality standards and capabilities. With this, the company can start selling Ibuprofen in the European markets. The company will continue to explore avenues to further grow the revenue from Ibuprofen.

The company's growth trajectory is expected to accelerate further, in the upcoming quarters underpinned by the recovery in the key products and further geographic expansion for Ibuprofen and other products. The Company is committed to meeting the highest quality standards and is further committed to be fully compliant with the GMP regulations at all our manufacturing facilities."

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 86.55 as compared to the previous close of Rs. 85.10. The total number of shares traded during the day was 3444 in over 251 trades.

The stock hit an intraday high of Rs. 87.90 and intraday low of 82.00. The net turnover during the day was Rs. 296320.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals INE812G01025 CEPApproval EDQM Ibuprofen